Mrs Elizabeth Keoshkerian

Lamoury FMJ; Hajarizadeh B; Keoshkerian E; Feld JJ; Amin J; Teutsch S; Matthews GV; Hellard M; Dore GJ; Lloyd AR; Applegate TL; Grebely J, 2016, 'HIV infection is associated with higher levels of monocyte chemoattractant protein-1 and eotaxin among people with recent hepatitis C virus infection', BMC Infectious Diseases, vol. 16, http://dx.doi.org/10.1186/s12879-016-1567-2

Hajarizadeh B; Lamoury FMJ; Feld JJ; Amin J; Keoshkerian E; Matthews GV; Hellard M; Dore GJ; Lloyd AR; Grebely J; Applegate TL, 2016, 'Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infection', Virology Journal, vol. 13, http://dx.doi.org/10.1186/s12985-016-0482-x

Marsden V; Donaghy H; Bertram KM; Harman AN; Nasr N; Keoshkerian E; Merten S; Lloyd AR; Cunningham AL, 2015, 'Herpes simplex virus type 2-infected dendritic cells produce TNF-α, which enhances CCR5 expression and stimulates HIV production from adjacent infected cells', Journal of Immunology, vol. 194, pp. 4438 - 4445, http://dx.doi.org/10.4049/jimmunol.1401706

Nguyen N; Luciani F; Cameron B; Keoshkerian E; Zekry A; Lloyd A, 2012, '801 T CELLS CO-EXPRESSING CCR2, CCR5, CXCR3, AND CXCR6 ARE PREFERENTIALLY ENRICHED IN THE HCV-INFECTED LIVER', Journal of Hepatology, vol. 56, pp. S313 - S313, http://dx.doi.org/10.1016/s0168-8278(12)60813-7

Kelleher AD; Puls R; Bebbington M; Boyle D; Kent S; Kippax SC; Purcell D; Thomson S; Wand HC; Cooper DA; Emery S; Ffrench RA, 2006, 'A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophylactic vaccine for HIV-1', AIDS, vol. 20, pp. 294 - 297, http://dx.doi.org/10.1097/01.aids.0000199819.40079.e9

Chen K; Chen L; Zhao P; Marrero L; Keoshkerian E; Ramsay A; Cui Y, 2005, 'FL-CTL assay: fluorolysometric determination of cell-mediated cytotoxicity using green fluorescent protein and red fluorescent protein expressing target cells.', J Immunol Methods, vol. 300, pp. 100 - 114, http://dx.doi.org/10.1016/j.jim.2005.02.010

Keoshkerian E; Happel KI; Lockhart EA; Mason CM; Poretta E; Odden AR; Nelson S; Ramsay AJ, 2005, 'Pulmonary interlukin-23 gene delivery increases local T-cell immunity and controls growth of Mycobacterium tuberculosis in the lungs.', Infectious Immunology, vol. 73, pp. 5782 - 5788

Keoshkerian E; Ashton LJ; Smith DG; Ziegler JB; Kaldor JM; Cooper DA; Stewart GJ; Ffrench R, 2003, 'Effector HIV-specific cytotoxic T lymphocyte activity in HIV non-progressors correlates with viral replication and progression', Journal of Medical Virology, vol. 71, pp. 483 - 491, http://dx.doi.org/10.1002/jmv.10525

Hicks C; Keoshkerian E; Gaudry L; Lindeman R, 2001, 'CD80 (B7-1) expression on human acute myeloid leukaemic cells cultured with GM-CSF, IL-3 and IL-6', Cancer Immunology, Immunotherapy, vol. 50, pp. 173 - 180, http://dx.doi.org/10.1007/PL00006686

Keoshkerian E; Hicks C; Lindeman R, 2001, 'Adenoviral mediated IL-2 gene transfer to human long-term bone marrow stromal cultures.', Cancer Biotherapy and Radiopharmaceuticals, vol. 16, pp. 537 - 542, http://dx.doi.org/10.1089/10849780152752137

Keoshkerian E; Hicks C; Gaudry L; Lindeman R, 2000, 'B7.1 (CD80) expression on human acute myeloid leukaemia cells cultured with GM-CSF, IL-3, and IL-6.', Cancer Immunology and Immunotherapy, vol. 50, pp. 173 - 180

Minter AJ; Keoshkerian E; Chesterman CN; Dawes J, 1996, 'Fibroblast growth factor and heparin protect endothelial cells from the effects of interleukin 1', Journal of Cellular Physiology, vol. 167, pp. 229 - 237, http://dx.doi.org/10.1002/(SICI)1097-4652(199605)167:2<229::AID-JCP6>3.0.CO;2-R